Drug Delivery Devices Market Size, Share, Trends, Growth Outlook |2025-2034

The Global Drug Delivery Devices Market Size is estimated at $582.4 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 7.3% to reach $1098 Billion by 2034.

The Drug Delivery Devices Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Route of Administration (Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical, Others), By Application (Oncology, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others), By End-user (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others).

An Introduction to Drug Delivery Devices Market in 2025

The drug delivery devices market in 2025 addresses the demand for innovative medical devices and technologies used to administer therapeutic agents, medications, and biologics to patients for the treatment of various diseases and medical conditions. Drug delivery devices encompass a wide range of products, including inhalers, injectors, patches, pumps, and implants, designed to deliver drugs through oral, parenteral, transdermal, pulmonary, nasal, ocular, and other routes of administration. They play a crucial role in precision medicine, personalized drug dosing, and targeted therapy delivery, improving patient compliance, therapeutic efficacy, and safety profiles. Market dynamics are driven by factors such as the increasing prevalence of chronic diseases, the growing demand for patient-centric drug delivery solutions, and advancements in device design, materials, and connectivity for enhanced drug delivery performance and patient convenience. Collaboration between medical device manufacturers, pharmaceutical companies, and healthcare providers drives innovation and market expansion in drug delivery devices, supporting improved treatment outcomes and healthcare delivery across diverse therapeutic areas and patient populations.

Drug Delivery Devices Market Competitive Landscape

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments across Altaris, Bayer AG, Becton, Dickinson and Company, Biocorp, Elcam Medical, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Holozymes Inc (Antares Pharma Inc), Johnson and Johnson, Merck KGaA, Molex (Philips Medisize), Novartis AG, Pfizer Inc, Teva Pharmaceutical Industries Ltd, West Pharmaceutical Services Inc

Drug Delivery Devices Market Dynamics

Market Trend: Growing Demand for Self-Administered Drug Delivery Solutions

A significant trend in the Drug Delivery Devices market is the growing demand for self-administered drug delivery solutions. With the increasing prevalence of chronic diseases and the shift towards personalized medicine, there is a rising need for convenient and patient-friendly drug delivery devices that allow individuals to administer medications safely and effectively at home. This trend is driven by factors such as the aging population, the rise in lifestyle-related chronic conditions, and the desire for improved patient adherence to treatment regimens. Additionally, advancements in technology, such as connected devices and smart drug delivery systems, are enabling greater control and monitoring of drug administration, further enhancing patient convenience and medication management. As healthcare systems prioritize patient-centered care and remote monitoring, the demand for innovative drug delivery devices that empower patients to take control of their treatment is expected to increase, driving market growth in the Drug Delivery Devices segment.

Market Driver: Advancements in Drug Formulations and Therapeutic Modalities

A key driver in the Drug Delivery Devices market is the advancements in drug formulations and therapeutic modalities. The development of novel drug formulations, including biologics, gene therapies, and nanoparticle-based drugs, has expanded the range of therapeutic options available to patients. However, many of these advanced therapeutics require specialized drug delivery devices to ensure optimal efficacy, stability, and targeted delivery to the site of action. This driver is fueled by the increasing investment in pharmaceutical research and development, the growing pipeline of complex and high-value therapeutics, and the need for innovative drug delivery solutions to overcome biological barriers and improve patient outcomes. As pharmaceutical companies seek to differentiate their products and gain market approval for advanced therapies, the demand for customized drug delivery devices tailored to specific formulations and therapeutic modalities is expected to escalate, driving market growth in the Drug Delivery Devices segment.

Market Opportunity: Integration of Digital Health Technologies and Connectivity Features

An opportunity for growth in the Drug Delivery Devices market lies in the integration of digital health technologies and connectivity features into drug delivery devices. With the rise of telemedicine, remote patient monitoring, and digital therapeutics, there is a growing demand for drug delivery devices that can collect and transmit data related to medication adherence, dosage tracking, and patient health metrics. By incorporating sensors, wireless connectivity, and smartphone apps into drug delivery devices, manufacturers can enhance medication management, improve treatment outcomes, and provide valuable insights for healthcare providers and patients. Additionally, connected drug delivery devices can facilitate real-time monitoring and intervention, enabling personalized dosing regimens and remote adjustments based on patient feedback and clinical data. By embracing opportunities for digital health integration and connectivity features, manufacturers can position themselves at the forefront of patient-centered care and capitalize on the growing demand for smart drug delivery solutions in the evolving healthcare landscape. Embracing innovation and connectivity presents a compelling avenue for market differentiation and sustained growth in the Drug Delivery Devices segment, offering solutions that improve medication adherence, patient outcomes, and overall healthcare delivery.

Drug Delivery Devices Market Share Analysis: Injectable Segment is Expected to Generate the Highest Revenue in 2025.

The injectable segment is anticipated to dominate the global drug delivery devices market in terms of revenue in 2025, driven by the rising prevalence of chronic diseases such as diabetes, cancer, and autoimmune disorders that require routine parenteral administration. This mode of delivery ensures faster absorption and improved bioavailability, making it a preferred choice for biologics and targeted therapies. The growing adoption of self-injectable devices, such as prefilled syringes, autoinjectors, and wearable injectors, is further transforming patient-centric care, especially in home settings. Innovation in needle-free injection technologies and sustained-release formulations is enhancing patient compliance while minimizing the risks associated with traditional syringes. Pharmaceutical companies are increasingly focusing on developing long-acting injectables and smart delivery systems that integrate digital health features, enabling real-time monitoring and dosing accuracy. Compared to other routes such as oral or transdermal, injectables offer superior control over pharmacokinetics, which is particularly beneficial in critical care and emergency applications. Additionally, the increasing number of biologic drugs in development pipelines is expected to fuel demand for advanced injectable delivery solutions, consolidating the segment’s leadership through 2025.

Drug Delivery Devices Market Share Analysis: Oncology Segment to Witness the Fastest Growth Rate (CAGR) over the forecast period from 2025 to 2034.

The Oncology segment is anticipated to be the fastest-growing in the drug delivery devices market over the forecast period to 2034. This growth is primarily driven by the increasing prevalence of cancer worldwide, coupled with advancements in personalized medicine and targeted drug delivery systems. Oncology treatments often require precise drug delivery to ensure maximum therapeutic efficacy while minimizing side effects, making the demand for advanced drug delivery devices, such as injectable and implantable systems, more pronounced. Additionally, innovations like nanoparticle-based drug delivery, which enables enhanced targeting of tumor cells, and the growing adoption of immunotherapy and biologics, further contribute to the rapid expansion of the oncology application within the market. With the continuous rise in cancer diagnoses and the need for more effective treatment methods, oncology is set to drive the highest demand for specialized drug delivery solutions.

Drug Delivery Devices Market Segmentation

By Route of Administration

• Oral
• Inhalation
• Transdermal
• Injectable
• Ocular
• Nasal
• Topical
• Others

By Application

• Oncology
• Infectious Diseases
• Respiratory Diseases
• Diabetes
• Cardiovascular Diseases
• Autoimmune Diseases
• Central Nervous System Disorders
• Others

By End-user

• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers/Clinics
• Home Care Settings
• Others

Geographical Analysis

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
• Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
• South America (Brazil, Argentina, Rest of South America)
• Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Drug Delivery Devices Companies Profiled in the Study

• Altaris
• Bayer AG
• Becton, Dickinson and Company
• Biocorp
• Elcam Medical
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline PLC
• Holozymes Inc (Antares Pharma Inc)
• Johnson and Johnson
• Merck KGaA
• Molex (Philips Medisize)
• Novartis AG
• Pfizer Inc
• Teva Pharmaceutical Industries Ltd
• West Pharmaceutical Services Inc

 *List not Exhaustive

Reasons to Buy the Drug Delivery Devices Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Drug Delivery Devices Market, encompassing current market size, growth trends, and forecasts till 2034.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Drug Delivery Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 Drug Delivery Devices Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global Drug Delivery Devices Market Size Outlook, $ Million, 2021 to 2030

3.2 Drug Delivery Devices Market Outlook By Type, $ Million, 2021 to 2030

3.3 Drug Delivery Devices Market Outlook By Product, $ Million, 2021 to 2030

3.4 Drug Delivery Devices Market Outlook By Application, $ Million, 2021 to 2030

3.5 Drug Delivery Devices Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of Drug Delivery Devices Market Industry

4.2 Key Market Trends in Drug Delivery Devices Market Industry

4.3 Potential Opportunities in Drug Delivery Devices Market Industry

4.4 Key Challenges in Drug Delivery Devices Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global Drug Delivery Devices Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global Drug Delivery Devices Market Outlook By Segments

7.1 Drug Delivery Devices Market Outlook by Segments

By Route of Administration

Oral

Inhalation

Transdermal

Injectable

Ocular

Nasal

Topical

Others

By Application

Oncology

Infectious Diseases

Respiratory Diseases

Diabetes

Cardiovascular Diseases

Autoimmune Diseases

Central Nervous System Disorders

Others

By End-user

Hospitals

Diagnostic Centers

Ambulatory Surgery Centers/Clinics

Home Care Settings

Others

 

8 North America Drug Delivery Devices Market Analysis And Outlook To 2030

8.1 Introduction to North America Drug Delivery Devices Markets in 2024

8.2 North America Drug Delivery Devices Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America Drug Delivery Devices Market size Outlook by Segments, 2021-2030

By Route of Administration

Oral

Inhalation

Transdermal

Injectable

Ocular

Nasal

Topical

Others

By Application

Oncology

Infectious Diseases

Respiratory Diseases

Diabetes

Cardiovascular Diseases

Autoimmune Diseases

Central Nervous System Disorders

Others

By End-user

Hospitals

Diagnostic Centers

Ambulatory Surgery Centers/Clinics

Home Care Settings

Others

 

9 Europe Drug Delivery Devices Market Analysis And Outlook To 2030

9.1 Introduction to Europe Drug Delivery Devices Markets in 2024

9.2 Europe Drug Delivery Devices Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe Drug Delivery Devices Market Size Outlook By Segments, 2021-2030

By Route of Administration

Oral

Inhalation

Transdermal

Injectable

Ocular

Nasal

Topical

Others

By Application

Oncology

Infectious Diseases

Respiratory Diseases

Diabetes

Cardiovascular Diseases

Autoimmune Diseases

Central Nervous System Disorders

Others

By End-user

Hospitals

Diagnostic Centers

Ambulatory Surgery Centers/Clinics

Home Care Settings

Others

 

10 Asia Pacific Drug Delivery Devices Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific Drug Delivery Devices Markets in 2024

10.2 Asia Pacific Drug Delivery Devices Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific Drug Delivery Devices Market size Outlook by Segments, 2021-2030

By Route of Administration

Oral

Inhalation

Transdermal

Injectable

Ocular

Nasal

Topical

Others

By Application

Oncology

Infectious Diseases

Respiratory Diseases

Diabetes

Cardiovascular Diseases

Autoimmune Diseases

Central Nervous System Disorders

Others

By End-user

Hospitals

Diagnostic Centers

Ambulatory Surgery Centers/Clinics

Home Care Settings

Others

 

11 South America Drug Delivery Devices Market Analysis And Outlook To 2030

11.1 Introduction to South America Drug Delivery Devices Markets in 2024

11.2 South America Drug Delivery Devices Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America Drug Delivery Devices Market size Outlook by Segments, 2021-2030

By Route of Administration

Oral

Inhalation

Transdermal

Injectable

Ocular

Nasal

Topical

Others

By Application

Oncology

Infectious Diseases

Respiratory Diseases

Diabetes

Cardiovascular Diseases

Autoimmune Diseases

Central Nervous System Disorders

Others

By End-user

Hospitals

Diagnostic Centers

Ambulatory Surgery Centers/Clinics

Home Care Settings

Others

 

12 Middle East And Africa Drug Delivery Devices Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa Drug Delivery Devices Markets in 2024

12.2 Middle East and Africa Drug Delivery Devices Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa Drug Delivery Devices Market size Outlook by Segments, 2021-2030

By Route of Administration

Oral

Inhalation

Transdermal

Injectable

Ocular

Nasal

Topical

Others

By Application

Oncology

Infectious Diseases

Respiratory Diseases

Diabetes

Cardiovascular Diseases

Autoimmune Diseases

Central Nervous System Disorders

Others

By End-user

Hospitals

Diagnostic Centers

Ambulatory Surgery Centers/Clinics

Home Care Settings

Others

 

13 Company Profiles

13.1  Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

Altaris

Bayer AG

Becton, Dickinson and Company

Biocorp

Elcam Medical

F. Hoffmann-La Roche Ltd

GlaxoSmithKline PLC

Holozymes Inc (Antares Pharma Inc)

Johnson and Johnson

Merck KGaA

Molex (Philips Medisize)

Novartis AG

Pfizer Inc

Teva Pharmaceutical Industries Ltd

West Pharmaceutical Services Inc

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

Drug Delivery Devices Market Segmentation

By Route of Administration

• Oral
• Inhalation
• Transdermal
• Injectable
• Ocular
• Nasal
• Topical
• Others

By Application

• Oncology
• Infectious Diseases
• Respiratory Diseases
• Diabetes
• Cardiovascular Diseases
• Autoimmune Diseases
• Central Nervous System Disorders
• Others

By End-user

• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers/Clinics
• Home Care Settings
• Others

Geographical Analysis

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
• Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
• South America (Brazil, Argentina, Rest of South America)
• Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)